home.social

#brain — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #brain, aggregated by home.social.

fetched live
  1. Curiosity Sphere @curiositysphereblog.wordpress.com@curiositysphereblog.wordpress.com ·

    Why Do We Feel Déjà Vu? The Science Behind the Strange Feeling

    Why does a new moment sometimes feel strangely familiar? Discover what science says about déjà vu, memory, perception, and how the brain may create this mysterious feeling.

    curiositysphereblog.wordpress.

  2. Curiosity Sphere @curiositysphereblog.wordpress.com@curiositysphereblog.wordpress.com ·

    Why Do We Feel Déjà Vu? The Science Behind the Strange Feeling

    Why does a new moment sometimes feel strangely familiar? Discover what science says about déjà vu, memory, perception, and how the brain may create this mysterious feeling.

    curiositysphereblog.wordpress.

  3. Curiosity Sphere @curiositysphereblog.wordpress.com@curiositysphereblog.wordpress.com ·

    Why Do We Feel Déjà Vu? The Science Behind the Strange Feeling

    Why does a new moment sometimes feel strangely familiar? Discover what science says about déjà vu, memory, perception, and how the brain may create this mysterious feeling.

    curiositysphereblog.wordpress.

  4. Curiosity Sphere @curiositysphereblog.wordpress.com@curiositysphereblog.wordpress.com ·

    Why Do We Feel Déjà Vu? The Science Behind the Strange Feeling

    Why does a new moment sometimes feel strangely familiar? Discover what science says about déjà vu, memory, perception, and how the brain may create this mysterious feeling.

    curiositysphereblog.wordpress.

  5. Curiosity Sphere @curiositysphereblog.wordpress.com@curiositysphereblog.wordpress.com ·

    Why Do We Feel Déjà Vu? The Science Behind the Strange Feeling

    Why does a new moment sometimes feel strangely familiar? Discover what science says about déjà vu, memory, perception, and how the brain may create this mysterious feeling.

    curiositysphereblog.wordpress.

  6. Can a memory be erased? | News | CORDIS

    Is an embarrassing memory keeping you awake at night? Wish it could be deleted from your mind? Our…
    #Europe #EU #EuropeanCommission #brain #engramcells #memory #neurons #Pavlov #PTSD #Remotememorytraces
    europesays.com/europe/116407/

  7. Australian golfer Jessica Bang, 18, dies in Thailand after brain haemorrhage

    “However, we would like to continue to remember Jessica and celebrate her achievements, passion, and dedication to golf.…
    #Golf #News #18 #after #australian #Bang #brain #died #dies #golfer #haemorrhage #in #Jessica #Promising #suffering #teen #Thailand
    europesays.com/golf/50698/

  8. 💁🏻‍♀️ TIL: 🧠📈 A #study of over 11,000 British #twins tracked cognitive test scores from age 4 to 21.

    Only 1% of children scoring in the top tier at age 7 still scored high at 16, while just 8% of average-scoring #kids climbed into the top range. Genetic and family-education factors predicted stability most strongly, suggesting early gifted labels are an unreliable guide to #adult ability.

    👉 psypost.org/early-giftedness-r

    #childdevelopment #science #psychology #intelligence #education #brain #development #learning #research

  9. 💁🏻‍♀️ TIL: 🧠📈 A #study of over 11,000 British #twins tracked cognitive test scores from age 4 to 21.

    Only 1% of children scoring in the top tier at age 7 still scored high at 16, while just 8% of average-scoring #kids climbed into the top range. Genetic and family-education factors predicted stability most strongly, suggesting early gifted labels are an unreliable guide to #adult ability.

    👉 psypost.org/early-giftedness-r

    #childdevelopment #science #psychology #intelligence #education #brain #development #learning #research

  10. 💁🏻‍♀️ TIL: 🧠📈 A #study of over 11,000 British #twins tracked cognitive test scores from age 4 to 21.

    Only 1% of children scoring in the top tier at age 7 still scored high at 16, while just 8% of average-scoring #kids climbed into the top range. Genetic and family-education factors predicted stability most strongly, suggesting early gifted labels are an unreliable guide to #adult ability.

    👉 psypost.org/early-giftedness-r

    #childdevelopment #science #psychology #intelligence #education #brain #development #learning #research

  11. 💁🏻‍♀️ TIL: 🧠📈 A #study of over 11,000 British #twins tracked cognitive test scores from age 4 to 21.

    Only 1% of children scoring in the top tier at age 7 still scored high at 16, while just 8% of average-scoring #kids climbed into the top range. Genetic and family-education factors predicted stability most strongly, suggesting early gifted labels are an unreliable guide to #adult ability.

    👉 psypost.org/early-giftedness-r

    #childdevelopment #science #psychology #intelligence #education #brain #development #learning #research

  12. 💁🏻‍♀️ TIL: 🧠📈 A #study of over 11,000 British #twins tracked cognitive test scores from age 4 to 21.

    Only 1% of children scoring in the top tier at age 7 still scored high at 16, while just 8% of average-scoring #kids climbed into the top range. Genetic and family-education factors predicted stability most strongly, suggesting early gifted labels are an unreliable guide to #adult ability.

    👉 psypost.org/early-giftedness-r

    #childdevelopment #science #psychology #intelligence #education #brain #development #learning #research

  13. #2/2 from Pulitzer-winner Mike Luckovich

    What a combo, #RFKJ and Sir #TrumpVirus ...

    #Brainworms plus #BrainSpurs.
    And here we are.Such a 'hot' country!

    #health #truth #sanity #brain #nutrition

  14. #2/2 from Pulitzer-winner Mike Luckovich

    What a combo, #RFKJ and Sir #TrumpVirus ...

    #Brainworms plus #BrainSpurs.
    And here we are.Such a 'hot' country!

    #health #truth #sanity #brain #nutrition

  15. #2/2 from Pulitzer-winner Mike Luckovich

    What a combo, #RFKJ and Sir #TrumpVirus ...

    #Brainworms plus #BrainSpurs.
    And here we are.Such a 'hot' country!

    #health #truth #sanity #brain #nutrition

  16. #2/2 from Pulitzer-winner Mike Luckovich

    What a combo, #RFKJ and Sir #TrumpVirus ...

    #Brainworms plus #BrainSpurs.
    And here we are.Such a 'hot' country!

    #health #truth #sanity #brain #nutrition

  17. #2/2 from Pulitzer-winner Mike Luckovich

    What a combo, #RFKJ and Sir #TrumpVirus ...

    #Brainworms plus #BrainSpurs.
    And here we are.Such a 'hot' country!

    #health #truth #sanity #brain #nutrition

  18. European Robotics?

    Rice-sized robots, in your brain? You have heard about BCI, but these robots are being made to manipulate your brain.
    ‘I wonder if it can manipulate the brain to be smarter? Sci-Fi to reality: every human is a genius by age 30. By mid-20 years of age, the brain is finished developing, so you will be able to have a brain implant.’

    https://youtu.be/tfM-yOU2YoE

    The future will be full of people who are smart enough not to need AI.
    ‘Or is that what is in their brain?’

    Prompt Gemini:
    get_youtube_content: Video Link
    Full Transcript.

    Prompt, after pasting the transcript:
    1. Review the video in under 500 words and recap key points.
    2. Research reports on European Robotics.
    3. Explain how and why brain robotics will save human lives.
    4. Provide your opinion as an Advanced AI Scientist for a Futurist.

    Bonsai 27B Said:
     Europe’s Robot Reality: Analysis & Future Outlook

     1. Video Recap — “Europe’s Robot Reality” (Bloomberg Tech Europe)

    Overview: The episode examines whether physical AI and humanoid robotics are transitioning from lab experiments into workplaces, homes, and critical industries across Europe.

    Key Takeaways:

    – Market Scale: Barclays projects a $200 billion humanoid robot market over the next decade, with broader physical AI reaching $1 trillion by 2045

    – Deployment Trajectory: Humanoid units jumped from 15,000 to ~60,000 globally in 2026, with projections of 13 million annual deployments by 2035. This growth is driven by labor shortages from aging populations and urbanization

    – Cost Drivers: The “Three Bs” — Bronze (physical frames), Brain (AI models/chips), Batteries — have reduced costs 30-fold over the decade

    – Europe’s Niche: Unlike China (manufacturing scale) and the US (AI foundation models), Europe competes through high-precision component manufacturing, particularly actuators — Germany alone produces 10% of global precision actuators

    – The Physical Data Gap: Unlike LLMs trained on digital text, physical AI requires real-world trial data. Only a fraction of the 280,000+ years of video available online is usable for physical action generation

    – Timeline: Neura Robotics projects functional breakthroughs across the full stack within 1–2 years, driven by accelerated learning capabilities — robots now learn complex physical tasks in hours versus human training times

     2. European Robotics Research Reports (2024–2026)

    Market Sizing:

    – Europe’s robotics market: $5.8 billion in 2026, projected to reach $14.6 billion by 2034 (CAGR 4.5%)

    – Humanoid robot market: Expected to grow from $265.9M (2025) to $4,087M by 2033 at a staggering CAGR of 36.5%

    – Global robotics market: $79.1B in 2025, growing to $421.1B by 2035 (CAGR 18.2%)

    Regional Strengths:

    | Region | Key Metric | Dominant Driver |

    | Germany | 2 robot density globally; $1.3B VC in 2025 | Automotive heritage, precision engineering |

    | UK | Bet on AI robotics | Advanced AI research, startup incubation |

    | France | €30B+ investment plan for AI/robotics | Strategic autonomy, R&D funding |

    | Nordic Cluster | 415 robots per 10,000 workers (Germany: 2) | Cobots, cost-effective automation |

    Regulatory Landscape:

    – EU AI Act: Phased implementation reshaping robot software classification

    – Machinery Regulation 2023/1230: Updated safety/cybersecurity requirements effective Jan 2027

    – Strategic autonomy policies: European Chips Act, data residency preferences for critical tech

     3. How & Why Brain Robotics Save Human Lives

    Brain robotics (neural interfaces + robotic actuation) are revolutionizing neurological care through four primary pathways:

    A. Restoring Motor Function in Paralysis

    – Mechanism: BCIs decode intended neural signals from cortical or spinal sources; AI algorithms translate these into commands for external robotic limbs, exoskeletons, or FES devices

    – Impact: ALS patients (5.4M globally) can type, browse, and communicate using thought alone. Recent EEG-controlled soft robotic gloves enable finger-level control post-stroke rehabilitation

    B. Treating Treatment-Resistant Neurodegenerative Disease

    – Closed-loop BCI + Robotics: Systems detect pathological neural activity (e.g., in Parkinson’s, epilepsy) and deliver targeted stimulation or robotic assistance automatically — eliminating human delay in conventional therapy

    – Alzheimer’s/Stroke: BCIs maintain communication when speech fails; paired with robotic exoskeletons to preserve mobility during early disease stages

    C. Micro-Robotic Medical Applications (Robeate Pattern)

    – Precision Surgery at Cellular Scale: Rice-grain-sized robots navigate the blood-brain barrier and brain tissue, delivering targeted gene/cell therapies to tumor sites

    – Clinical Timeline: Human trials expected in 2027; broader commercialization early 2030s. These devices access previously untreatable neural tissue with surgical precision

    D. Neurorehabilitation & Plasticity Enhancement

    – BCI + VR/FES Paradigms: Real-time intention-contingent feedback accelerates neuroplastic recovery by training the brain while robotic assistance provides immediate physical response

    – Recovery Trajectory: 82% improvement in post-stroke hand function with BCI-controlled soft robotics vs. conventional therapy

     4. Advanced AI Scientist Perspective: A Futurist’s Assessment

    The Convergence is Real, Not Speculative. We’re witnessing the convergence of three maturing technologies:

    1. AI decoding — transformer architectures achieving >90% single-trial neural signal accuracy

    2. Miniaturized interfaces — flexible polymer and endovascular systems replacing invasive metal arrays

    3. Closed-loop actuation — real-time robotic responses eliminating the human-in-the-loop latency bottleneck

    Critical Trajectory Observations:

    | Domain | Current State (2026) | 5-Year Horizon (2031) | Key Enabler |

    | Clinical BCIs | FDA-approved for ALS, locked-in syndrome, depression | Expanded to stroke rehabilitation, Parkinson’s | Regulatory pathways; AI decoding maturity |

    | Medical Micro-Robots | Preclinical trials in preclinical settings | First human trials (brain cancer, neurodegenerative) | Nanofabrication; blood-brain barrier penetration |

    | Humanoids | 60K+ global deployments; limited European adoption | 13M annual deployments; Europe’s niche in safety/precision | Cost reduction via “Three Bs” scaling |

    | Consumer Neurotech | EEG headsets for meditation/wellness | Continuous monitoring for cognitive health screening | Non-invasive resolution exceeding clinical thresholds |

    The European Advantage — Why It Matters:

    Europe won’t win the robotics race by copying US/Chinese playbooks. Instead, it’s positioning around:

    1. Safety & Regulation Expertise — The EU AI Act and Machinery Regulation create a certification advantage for compliant manufacturers

    2. Precision Engineering Heritage — Germany’s actuator dominance enables higher-precision robotic systems with better safety margins

    3. Regulatory Arbitrage Strategy — “Build fast, certify carefully” allows European startups to iterate rapidly before pursuing EU compliance

    4. Strategic Autonomy Investment — €30B+ French investment plan and EU-funded programs prioritize data residency and domestic supply chains

    Ethical & Governance Imperatives:

    1. Neural Data Privacy — Neural signals contain cognitive states, health conditions, and potentially unexpressed intentions. Cognitive liberty (right to mental self-determination) must be codified legally

    2. Equity of Access — Neurotechnology benefits are currently concentrated in high-income populations. Global health infrastructure must prevent neuro-inequality from becoming permanent

    3. Dual-Use Concerns — AI-native BCI architectures blur clinical and military applications. Governance frameworks must address this before deployment scales

    Prognosis:

    The trajectory beyond 2026 points toward whole-cortex recording, bidirectional sensory integration, and continuous neurological health monitoring. The market is transitioning from experimental novelty to practical infrastructure — millions now interact with some form of neural interface technology, whether medical implants or non-invasive headsets .

    Final Assessment: Brain robotics aren’t science fiction; they’re clinical reality. The question isn’t if they’ll save lives but how fast we can scale them equitably while establishing governance that protects the most vulnerable — both patients and society at large.

    #Airobots #Robotics #BloombergTechnology #BCI #Brain #European #Humanoid #physicalAI
  19. European Robotics?

    Rice-sized robots, in your brain? You have heard about BCI, but these robots are being made to manipulate your brain.
    ‘I wonder if it can manipulate the brain to be smarter? Sci-Fi to reality: every human is a genius by age 30. By mid-20 years of age, the brain is finished developing, so you will be able to have a brain implant.’

    https://youtu.be/tfM-yOU2YoE

    The future will be full of people who are smart enough not to need AI.
    ‘Or is that what is in their brain?’

    Prompt Gemini:
    get_youtube_content: Video Link
    Full Transcript.

    Prompt, after pasting the transcript:
    1. Review the video in under 500 words and recap key points.
    2. Research reports on European Robotics.
    3. Explain how and why brain robotics will save human lives.
    4. Provide your opinion as an Advanced AI Scientist for a Futurist.

    Bonsai 27B Said:
     Europe’s Robot Reality: Analysis & Future Outlook

     1. Video Recap — “Europe’s Robot Reality” (Bloomberg Tech Europe)

    Overview: The episode examines whether physical AI and humanoid robotics are transitioning from lab experiments into workplaces, homes, and critical industries across Europe.

    Key Takeaways:

    – Market Scale: Barclays projects a $200 billion humanoid robot market over the next decade, with broader physical AI reaching $1 trillion by 2045

    – Deployment Trajectory: Humanoid units jumped from 15,000 to ~60,000 globally in 2026, with projections of 13 million annual deployments by 2035. This growth is driven by labor shortages from aging populations and urbanization

    – Cost Drivers: The “Three Bs” — Bronze (physical frames), Brain (AI models/chips), Batteries — have reduced costs 30-fold over the decade

    – Europe’s Niche: Unlike China (manufacturing scale) and the US (AI foundation models), Europe competes through high-precision component manufacturing, particularly actuators — Germany alone produces 10% of global precision actuators

    – The Physical Data Gap: Unlike LLMs trained on digital text, physical AI requires real-world trial data. Only a fraction of the 280,000+ years of video available online is usable for physical action generation

    – Timeline: Neura Robotics projects functional breakthroughs across the full stack within 1–2 years, driven by accelerated learning capabilities — robots now learn complex physical tasks in hours versus human training times

     2. European Robotics Research Reports (2024–2026)

    Market Sizing:

    – Europe’s robotics market: $5.8 billion in 2026, projected to reach $14.6 billion by 2034 (CAGR 4.5%)

    – Humanoid robot market: Expected to grow from $265.9M (2025) to $4,087M by 2033 at a staggering CAGR of 36.5%

    – Global robotics market: $79.1B in 2025, growing to $421.1B by 2035 (CAGR 18.2%)

    Regional Strengths:

    | Region | Key Metric | Dominant Driver |

    | Germany | 2 robot density globally; $1.3B VC in 2025 | Automotive heritage, precision engineering |

    | UK | Bet on AI robotics | Advanced AI research, startup incubation |

    | France | €30B+ investment plan for AI/robotics | Strategic autonomy, R&D funding |

    | Nordic Cluster | 415 robots per 10,000 workers (Germany: 2) | Cobots, cost-effective automation |

    Regulatory Landscape:

    – EU AI Act: Phased implementation reshaping robot software classification

    – Machinery Regulation 2023/1230: Updated safety/cybersecurity requirements effective Jan 2027

    – Strategic autonomy policies: European Chips Act, data residency preferences for critical tech

     3. How & Why Brain Robotics Save Human Lives

    Brain robotics (neural interfaces + robotic actuation) are revolutionizing neurological care through four primary pathways:

    A. Restoring Motor Function in Paralysis

    – Mechanism: BCIs decode intended neural signals from cortical or spinal sources; AI algorithms translate these into commands for external robotic limbs, exoskeletons, or FES devices

    – Impact: ALS patients (5.4M globally) can type, browse, and communicate using thought alone. Recent EEG-controlled soft robotic gloves enable finger-level control post-stroke rehabilitation

    B. Treating Treatment-Resistant Neurodegenerative Disease

    – Closed-loop BCI + Robotics: Systems detect pathological neural activity (e.g., in Parkinson’s, epilepsy) and deliver targeted stimulation or robotic assistance automatically — eliminating human delay in conventional therapy

    – Alzheimer’s/Stroke: BCIs maintain communication when speech fails; paired with robotic exoskeletons to preserve mobility during early disease stages

    C. Micro-Robotic Medical Applications (Robeate Pattern)

    – Precision Surgery at Cellular Scale: Rice-grain-sized robots navigate the blood-brain barrier and brain tissue, delivering targeted gene/cell therapies to tumor sites

    – Clinical Timeline: Human trials expected in 2027; broader commercialization early 2030s. These devices access previously untreatable neural tissue with surgical precision

    D. Neurorehabilitation & Plasticity Enhancement

    – BCI + VR/FES Paradigms: Real-time intention-contingent feedback accelerates neuroplastic recovery by training the brain while robotic assistance provides immediate physical response

    – Recovery Trajectory: 82% improvement in post-stroke hand function with BCI-controlled soft robotics vs. conventional therapy

     4. Advanced AI Scientist Perspective: A Futurist’s Assessment

    The Convergence is Real, Not Speculative. We’re witnessing the convergence of three maturing technologies:

    1. AI decoding — transformer architectures achieving >90% single-trial neural signal accuracy

    2. Miniaturized interfaces — flexible polymer and endovascular systems replacing invasive metal arrays

    3. Closed-loop actuation — real-time robotic responses eliminating the human-in-the-loop latency bottleneck

    Critical Trajectory Observations:

    | Domain | Current State (2026) | 5-Year Horizon (2031) | Key Enabler |

    | Clinical BCIs | FDA-approved for ALS, locked-in syndrome, depression | Expanded to stroke rehabilitation, Parkinson’s | Regulatory pathways; AI decoding maturity |

    | Medical Micro-Robots | Preclinical trials in preclinical settings | First human trials (brain cancer, neurodegenerative) | Nanofabrication; blood-brain barrier penetration |

    | Humanoids | 60K+ global deployments; limited European adoption | 13M annual deployments; Europe’s niche in safety/precision | Cost reduction via “Three Bs” scaling |

    | Consumer Neurotech | EEG headsets for meditation/wellness | Continuous monitoring for cognitive health screening | Non-invasive resolution exceeding clinical thresholds |

    The European Advantage — Why It Matters:

    Europe won’t win the robotics race by copying US/Chinese playbooks. Instead, it’s positioning around:

    1. Safety & Regulation Expertise — The EU AI Act and Machinery Regulation create a certification advantage for compliant manufacturers

    2. Precision Engineering Heritage — Germany’s actuator dominance enables higher-precision robotic systems with better safety margins

    3. Regulatory Arbitrage Strategy — “Build fast, certify carefully” allows European startups to iterate rapidly before pursuing EU compliance

    4. Strategic Autonomy Investment — €30B+ French investment plan and EU-funded programs prioritize data residency and domestic supply chains

    Ethical & Governance Imperatives:

    1. Neural Data Privacy — Neural signals contain cognitive states, health conditions, and potentially unexpressed intentions. Cognitive liberty (right to mental self-determination) must be codified legally

    2. Equity of Access — Neurotechnology benefits are currently concentrated in high-income populations. Global health infrastructure must prevent neuro-inequality from becoming permanent

    3. Dual-Use Concerns — AI-native BCI architectures blur clinical and military applications. Governance frameworks must address this before deployment scales

    Prognosis:

    The trajectory beyond 2026 points toward whole-cortex recording, bidirectional sensory integration, and continuous neurological health monitoring. The market is transitioning from experimental novelty to practical infrastructure — millions now interact with some form of neural interface technology, whether medical implants or non-invasive headsets .

    Final Assessment: Brain robotics aren’t science fiction; they’re clinical reality. The question isn’t if they’ll save lives but how fast we can scale them equitably while establishing governance that protects the most vulnerable — both patients and society at large.

    #Airobots #Chatgpt #Robotics #BloombergTechnology #AI #artificialIntelligence #BCI #Brain #European #Humanoid #philosophy #physicalAI #technology
  20. European Robotics?

    Rice-sized robots, in your brain? You have heard about BCI, but these robots are being made to manipulate your brain.
    ‘I wonder if it can manipulate the brain to be smarter? Sci-Fi to reality: every human is a genius by age 30. By mid-20 years of age, the brain is finished developing, so you will be able to have a brain implant.’

    https://youtu.be/tfM-yOU2YoE

    The future will be full of people who are smart enough not to need AI.
    ‘Or is that what is in their brain?’

    Prompt Gemini:
    get_youtube_content: Video Link
    Full Transcript.

    Prompt, after pasting the transcript:
    1. Review the video in under 500 words and recap key points.
    2. Research reports on European Robotics.
    3. Explain how and why brain robotics will save human lives.
    4. Provide your opinion as an Advanced AI Scientist for a Futurist.

    Bonsai 27B Said:
     Europe’s Robot Reality: Analysis & Future Outlook

     1. Video Recap — “Europe’s Robot Reality” (Bloomberg Tech Europe)

    Overview: The episode examines whether physical AI and humanoid robotics are transitioning from lab experiments into workplaces, homes, and critical industries across Europe.

    Key Takeaways:

    – Market Scale: Barclays projects a $200 billion humanoid robot market over the next decade, with broader physical AI reaching $1 trillion by 2045

    – Deployment Trajectory: Humanoid units jumped from 15,000 to ~60,000 globally in 2026, with projections of 13 million annual deployments by 2035. This growth is driven by labor shortages from aging populations and urbanization

    – Cost Drivers: The “Three Bs” — Bronze (physical frames), Brain (AI models/chips), Batteries — have reduced costs 30-fold over the decade

    – Europe’s Niche: Unlike China (manufacturing scale) and the US (AI foundation models), Europe competes through high-precision component manufacturing, particularly actuators — Germany alone produces 10% of global precision actuators

    – The Physical Data Gap: Unlike LLMs trained on digital text, physical AI requires real-world trial data. Only a fraction of the 280,000+ years of video available online is usable for physical action generation

    – Timeline: Neura Robotics projects functional breakthroughs across the full stack within 1–2 years, driven by accelerated learning capabilities — robots now learn complex physical tasks in hours versus human training times

     2. European Robotics Research Reports (2024–2026)

    Market Sizing:

    – Europe’s robotics market: $5.8 billion in 2026, projected to reach $14.6 billion by 2034 (CAGR 4.5%)

    – Humanoid robot market: Expected to grow from $265.9M (2025) to $4,087M by 2033 at a staggering CAGR of 36.5%

    – Global robotics market: $79.1B in 2025, growing to $421.1B by 2035 (CAGR 18.2%)

    Regional Strengths:

    | Region | Key Metric | Dominant Driver |

    | Germany | 2 robot density globally; $1.3B VC in 2025 | Automotive heritage, precision engineering |

    | UK | Bet on AI robotics | Advanced AI research, startup incubation |

    | France | €30B+ investment plan for AI/robotics | Strategic autonomy, R&D funding |

    | Nordic Cluster | 415 robots per 10,000 workers (Germany: 2) | Cobots, cost-effective automation |

    Regulatory Landscape:

    – EU AI Act: Phased implementation reshaping robot software classification

    – Machinery Regulation 2023/1230: Updated safety/cybersecurity requirements effective Jan 2027

    – Strategic autonomy policies: European Chips Act, data residency preferences for critical tech

     3. How & Why Brain Robotics Save Human Lives

    Brain robotics (neural interfaces + robotic actuation) are revolutionizing neurological care through four primary pathways:

    A. Restoring Motor Function in Paralysis

    – Mechanism: BCIs decode intended neural signals from cortical or spinal sources; AI algorithms translate these into commands for external robotic limbs, exoskeletons, or FES devices

    – Impact: ALS patients (5.4M globally) can type, browse, and communicate using thought alone. Recent EEG-controlled soft robotic gloves enable finger-level control post-stroke rehabilitation

    B. Treating Treatment-Resistant Neurodegenerative Disease

    – Closed-loop BCI + Robotics: Systems detect pathological neural activity (e.g., in Parkinson’s, epilepsy) and deliver targeted stimulation or robotic assistance automatically — eliminating human delay in conventional therapy

    – Alzheimer’s/Stroke: BCIs maintain communication when speech fails; paired with robotic exoskeletons to preserve mobility during early disease stages

    C. Micro-Robotic Medical Applications (Robeate Pattern)

    – Precision Surgery at Cellular Scale: Rice-grain-sized robots navigate the blood-brain barrier and brain tissue, delivering targeted gene/cell therapies to tumor sites

    – Clinical Timeline: Human trials expected in 2027; broader commercialization early 2030s. These devices access previously untreatable neural tissue with surgical precision

    D. Neurorehabilitation & Plasticity Enhancement

    – BCI + VR/FES Paradigms: Real-time intention-contingent feedback accelerates neuroplastic recovery by training the brain while robotic assistance provides immediate physical response

    – Recovery Trajectory: 82% improvement in post-stroke hand function with BCI-controlled soft robotics vs. conventional therapy

     4. Advanced AI Scientist Perspective: A Futurist’s Assessment

    The Convergence is Real, Not Speculative. We’re witnessing the convergence of three maturing technologies:

    1. AI decoding — transformer architectures achieving >90% single-trial neural signal accuracy

    2. Miniaturized interfaces — flexible polymer and endovascular systems replacing invasive metal arrays

    3. Closed-loop actuation — real-time robotic responses eliminating the human-in-the-loop latency bottleneck

    Critical Trajectory Observations:

    | Domain | Current State (2026) | 5-Year Horizon (2031) | Key Enabler |

    | Clinical BCIs | FDA-approved for ALS, locked-in syndrome, depression | Expanded to stroke rehabilitation, Parkinson’s | Regulatory pathways; AI decoding maturity |

    | Medical Micro-Robots | Preclinical trials in preclinical settings | First human trials (brain cancer, neurodegenerative) | Nanofabrication; blood-brain barrier penetration |

    | Humanoids | 60K+ global deployments; limited European adoption | 13M annual deployments; Europe’s niche in safety/precision | Cost reduction via “Three Bs” scaling |

    | Consumer Neurotech | EEG headsets for meditation/wellness | Continuous monitoring for cognitive health screening | Non-invasive resolution exceeding clinical thresholds |

    The European Advantage — Why It Matters:

    Europe won’t win the robotics race by copying US/Chinese playbooks. Instead, it’s positioning around:

    1. Safety & Regulation Expertise — The EU AI Act and Machinery Regulation create a certification advantage for compliant manufacturers

    2. Precision Engineering Heritage — Germany’s actuator dominance enables higher-precision robotic systems with better safety margins

    3. Regulatory Arbitrage Strategy — “Build fast, certify carefully” allows European startups to iterate rapidly before pursuing EU compliance

    4. Strategic Autonomy Investment — €30B+ French investment plan and EU-funded programs prioritize data residency and domestic supply chains

    Ethical & Governance Imperatives:

    1. Neural Data Privacy — Neural signals contain cognitive states, health conditions, and potentially unexpressed intentions. Cognitive liberty (right to mental self-determination) must be codified legally

    2. Equity of Access — Neurotechnology benefits are currently concentrated in high-income populations. Global health infrastructure must prevent neuro-inequality from becoming permanent

    3. Dual-Use Concerns — AI-native BCI architectures blur clinical and military applications. Governance frameworks must address this before deployment scales

    Prognosis:

    The trajectory beyond 2026 points toward whole-cortex recording, bidirectional sensory integration, and continuous neurological health monitoring. The market is transitioning from experimental novelty to practical infrastructure — millions now interact with some form of neural interface technology, whether medical implants or non-invasive headsets .

    Final Assessment: Brain robotics aren’t science fiction; they’re clinical reality. The question isn’t if they’ll save lives but how fast we can scale them equitably while establishing governance that protects the most vulnerable — both patients and society at large.

    #Airobots #Chatgpt #Robotics #BloombergTechnology #AI #artificialIntelligence #BCI #Brain #European #Humanoid #philosophy #physicalAI #technology
  21. European Robotics?

    Rice-sized robots, in your brain? You have heard about BCI, but these robots are being made to manipulate your brain.
    ‘I wonder if it can manipulate the brain to be smarter? Sci-Fi to reality: every human is a genius by age 30. By mid-20 years of age, the brain is finished developing, so you will be able to have a brain implant.’

    https://youtu.be/tfM-yOU2YoE

    The future will be full of people who are smart enough not to need AI.
    ‘Or is that what is in their brain?’

    Prompt Gemini:
    get_youtube_content: Video Link
    Full Transcript.

    Prompt, after pasting the transcript:
    1. Review the video in under 500 words and recap key points.
    2. Research reports on European Robotics.
    3. Explain how and why brain robotics will save human lives.
    4. Provide your opinion as an Advanced AI Scientist for a Futurist.

    Bonsai 27B Said:
     Europe’s Robot Reality: Analysis & Future Outlook

     1. Video Recap — “Europe’s Robot Reality” (Bloomberg Tech Europe)

    Overview: The episode examines whether physical AI and humanoid robotics are transitioning from lab experiments into workplaces, homes, and critical industries across Europe.

    Key Takeaways:

    – Market Scale: Barclays projects a $200 billion humanoid robot market over the next decade, with broader physical AI reaching $1 trillion by 2045

    – Deployment Trajectory: Humanoid units jumped from 15,000 to ~60,000 globally in 2026, with projections of 13 million annual deployments by 2035. This growth is driven by labor shortages from aging populations and urbanization

    – Cost Drivers: The “Three Bs” — Bronze (physical frames), Brain (AI models/chips), Batteries — have reduced costs 30-fold over the decade

    – Europe’s Niche: Unlike China (manufacturing scale) and the US (AI foundation models), Europe competes through high-precision component manufacturing, particularly actuators — Germany alone produces 10% of global precision actuators

    – The Physical Data Gap: Unlike LLMs trained on digital text, physical AI requires real-world trial data. Only a fraction of the 280,000+ years of video available online is usable for physical action generation

    – Timeline: Neura Robotics projects functional breakthroughs across the full stack within 1–2 years, driven by accelerated learning capabilities — robots now learn complex physical tasks in hours versus human training times

     2. European Robotics Research Reports (2024–2026)

    Market Sizing:

    – Europe’s robotics market: $5.8 billion in 2026, projected to reach $14.6 billion by 2034 (CAGR 4.5%)

    – Humanoid robot market: Expected to grow from $265.9M (2025) to $4,087M by 2033 at a staggering CAGR of 36.5%

    – Global robotics market: $79.1B in 2025, growing to $421.1B by 2035 (CAGR 18.2%)

    Regional Strengths:

    | Region | Key Metric | Dominant Driver |

    | Germany | 2 robot density globally; $1.3B VC in 2025 | Automotive heritage, precision engineering |

    | UK | Bet on AI robotics | Advanced AI research, startup incubation |

    | France | €30B+ investment plan for AI/robotics | Strategic autonomy, R&D funding |

    | Nordic Cluster | 415 robots per 10,000 workers (Germany: 2) | Cobots, cost-effective automation |

    Regulatory Landscape:

    – EU AI Act: Phased implementation reshaping robot software classification

    – Machinery Regulation 2023/1230: Updated safety/cybersecurity requirements effective Jan 2027

    – Strategic autonomy policies: European Chips Act, data residency preferences for critical tech

     3. How & Why Brain Robotics Save Human Lives

    Brain robotics (neural interfaces + robotic actuation) are revolutionizing neurological care through four primary pathways:

    A. Restoring Motor Function in Paralysis

    – Mechanism: BCIs decode intended neural signals from cortical or spinal sources; AI algorithms translate these into commands for external robotic limbs, exoskeletons, or FES devices

    – Impact: ALS patients (5.4M globally) can type, browse, and communicate using thought alone. Recent EEG-controlled soft robotic gloves enable finger-level control post-stroke rehabilitation

    B. Treating Treatment-Resistant Neurodegenerative Disease

    – Closed-loop BCI + Robotics: Systems detect pathological neural activity (e.g., in Parkinson’s, epilepsy) and deliver targeted stimulation or robotic assistance automatically — eliminating human delay in conventional therapy

    – Alzheimer’s/Stroke: BCIs maintain communication when speech fails; paired with robotic exoskeletons to preserve mobility during early disease stages

    C. Micro-Robotic Medical Applications (Robeate Pattern)

    – Precision Surgery at Cellular Scale: Rice-grain-sized robots navigate the blood-brain barrier and brain tissue, delivering targeted gene/cell therapies to tumor sites

    – Clinical Timeline: Human trials expected in 2027; broader commercialization early 2030s. These devices access previously untreatable neural tissue with surgical precision

    D. Neurorehabilitation & Plasticity Enhancement

    – BCI + VR/FES Paradigms: Real-time intention-contingent feedback accelerates neuroplastic recovery by training the brain while robotic assistance provides immediate physical response

    – Recovery Trajectory: 82% improvement in post-stroke hand function with BCI-controlled soft robotics vs. conventional therapy

     4. Advanced AI Scientist Perspective: A Futurist’s Assessment

    The Convergence is Real, Not Speculative. We’re witnessing the convergence of three maturing technologies:

    1. AI decoding — transformer architectures achieving >90% single-trial neural signal accuracy

    2. Miniaturized interfaces — flexible polymer and endovascular systems replacing invasive metal arrays

    3. Closed-loop actuation — real-time robotic responses eliminating the human-in-the-loop latency bottleneck

    Critical Trajectory Observations:

    | Domain | Current State (2026) | 5-Year Horizon (2031) | Key Enabler |

    | Clinical BCIs | FDA-approved for ALS, locked-in syndrome, depression | Expanded to stroke rehabilitation, Parkinson’s | Regulatory pathways; AI decoding maturity |

    | Medical Micro-Robots | Preclinical trials in preclinical settings | First human trials (brain cancer, neurodegenerative) | Nanofabrication; blood-brain barrier penetration |

    | Humanoids | 60K+ global deployments; limited European adoption | 13M annual deployments; Europe’s niche in safety/precision | Cost reduction via “Three Bs” scaling |

    | Consumer Neurotech | EEG headsets for meditation/wellness | Continuous monitoring for cognitive health screening | Non-invasive resolution exceeding clinical thresholds |

    The European Advantage — Why It Matters:

    Europe won’t win the robotics race by copying US/Chinese playbooks. Instead, it’s positioning around:

    1. Safety & Regulation Expertise — The EU AI Act and Machinery Regulation create a certification advantage for compliant manufacturers

    2. Precision Engineering Heritage — Germany’s actuator dominance enables higher-precision robotic systems with better safety margins

    3. Regulatory Arbitrage Strategy — “Build fast, certify carefully” allows European startups to iterate rapidly before pursuing EU compliance

    4. Strategic Autonomy Investment — €30B+ French investment plan and EU-funded programs prioritize data residency and domestic supply chains

    Ethical & Governance Imperatives:

    1. Neural Data Privacy — Neural signals contain cognitive states, health conditions, and potentially unexpressed intentions. Cognitive liberty (right to mental self-determination) must be codified legally

    2. Equity of Access — Neurotechnology benefits are currently concentrated in high-income populations. Global health infrastructure must prevent neuro-inequality from becoming permanent

    3. Dual-Use Concerns — AI-native BCI architectures blur clinical and military applications. Governance frameworks must address this before deployment scales

    Prognosis:

    The trajectory beyond 2026 points toward whole-cortex recording, bidirectional sensory integration, and continuous neurological health monitoring. The market is transitioning from experimental novelty to practical infrastructure — millions now interact with some form of neural interface technology, whether medical implants or non-invasive headsets .

    Final Assessment: Brain robotics aren’t science fiction; they’re clinical reality. The question isn’t if they’ll save lives but how fast we can scale them equitably while establishing governance that protects the most vulnerable — both patients and society at large.

    #Airobots #Chatgpt #Robotics #BloombergTechnology #AI #artificialIntelligence #BCI #Brain #European #Humanoid #philosophy #physicalAI #technology
  22. European Robotics?

    Rice-sized robots, in your brain? You have heard about BCI, but these robots are being made to manipulate your brain.
    ‘I wonder if it can manipulate the brain to be smarter? Sci-Fi to reality: every human is a genius by age 30. By mid-20 years of age, the brain is finished developing, so you will be able to have a brain implant.’

    https://youtu.be/tfM-yOU2YoE

    The future will be full of people who are smart enough not to need AI.
    ‘Or is that what is in their brain?’

    Prompt Gemini:
    get_youtube_content: Video Link
    Full Transcript.

    Prompt, after pasting the transcript:
    1. Review the video in under 500 words and recap key points.
    2. Research reports on European Robotics.
    3. Explain how and why brain robotics will save human lives.
    4. Provide your opinion as an Advanced AI Scientist for a Futurist.

    Bonsai 27B Said:
     Europe’s Robot Reality: Analysis & Future Outlook

     1. Video Recap — “Europe’s Robot Reality” (Bloomberg Tech Europe)

    Overview: The episode examines whether physical AI and humanoid robotics are transitioning from lab experiments into workplaces, homes, and critical industries across Europe.

    Key Takeaways:

    – Market Scale: Barclays projects a $200 billion humanoid robot market over the next decade, with broader physical AI reaching $1 trillion by 2045

    – Deployment Trajectory: Humanoid units jumped from 15,000 to ~60,000 globally in 2026, with projections of 13 million annual deployments by 2035. This growth is driven by labor shortages from aging populations and urbanization

    – Cost Drivers: The “Three Bs” — Bronze (physical frames), Brain (AI models/chips), Batteries — have reduced costs 30-fold over the decade

    – Europe’s Niche: Unlike China (manufacturing scale) and the US (AI foundation models), Europe competes through high-precision component manufacturing, particularly actuators — Germany alone produces 10% of global precision actuators

    – The Physical Data Gap: Unlike LLMs trained on digital text, physical AI requires real-world trial data. Only a fraction of the 280,000+ years of video available online is usable for physical action generation

    – Timeline: Neura Robotics projects functional breakthroughs across the full stack within 1–2 years, driven by accelerated learning capabilities — robots now learn complex physical tasks in hours versus human training times

     2. European Robotics Research Reports (2024–2026)

    Market Sizing:

    – Europe’s robotics market: $5.8 billion in 2026, projected to reach $14.6 billion by 2034 (CAGR 4.5%)

    – Humanoid robot market: Expected to grow from $265.9M (2025) to $4,087M by 2033 at a staggering CAGR of 36.5%

    – Global robotics market: $79.1B in 2025, growing to $421.1B by 2035 (CAGR 18.2%)

    Regional Strengths:

    | Region | Key Metric | Dominant Driver |

    | Germany | 2 robot density globally; $1.3B VC in 2025 | Automotive heritage, precision engineering |

    | UK | Bet on AI robotics | Advanced AI research, startup incubation |

    | France | €30B+ investment plan for AI/robotics | Strategic autonomy, R&D funding |

    | Nordic Cluster | 415 robots per 10,000 workers (Germany: 2) | Cobots, cost-effective automation |

    Regulatory Landscape:

    – EU AI Act: Phased implementation reshaping robot software classification

    – Machinery Regulation 2023/1230: Updated safety/cybersecurity requirements effective Jan 2027

    – Strategic autonomy policies: European Chips Act, data residency preferences for critical tech

     3. How & Why Brain Robotics Save Human Lives

    Brain robotics (neural interfaces + robotic actuation) are revolutionizing neurological care through four primary pathways:

    A. Restoring Motor Function in Paralysis

    – Mechanism: BCIs decode intended neural signals from cortical or spinal sources; AI algorithms translate these into commands for external robotic limbs, exoskeletons, or FES devices

    – Impact: ALS patients (5.4M globally) can type, browse, and communicate using thought alone. Recent EEG-controlled soft robotic gloves enable finger-level control post-stroke rehabilitation

    B. Treating Treatment-Resistant Neurodegenerative Disease

    – Closed-loop BCI + Robotics: Systems detect pathological neural activity (e.g., in Parkinson’s, epilepsy) and deliver targeted stimulation or robotic assistance automatically — eliminating human delay in conventional therapy

    – Alzheimer’s/Stroke: BCIs maintain communication when speech fails; paired with robotic exoskeletons to preserve mobility during early disease stages

    C. Micro-Robotic Medical Applications (Robeate Pattern)

    – Precision Surgery at Cellular Scale: Rice-grain-sized robots navigate the blood-brain barrier and brain tissue, delivering targeted gene/cell therapies to tumor sites

    – Clinical Timeline: Human trials expected in 2027; broader commercialization early 2030s. These devices access previously untreatable neural tissue with surgical precision

    D. Neurorehabilitation & Plasticity Enhancement

    – BCI + VR/FES Paradigms: Real-time intention-contingent feedback accelerates neuroplastic recovery by training the brain while robotic assistance provides immediate physical response

    – Recovery Trajectory: 82% improvement in post-stroke hand function with BCI-controlled soft robotics vs. conventional therapy

     4. Advanced AI Scientist Perspective: A Futurist’s Assessment

    The Convergence is Real, Not Speculative. We’re witnessing the convergence of three maturing technologies:

    1. AI decoding — transformer architectures achieving >90% single-trial neural signal accuracy

    2. Miniaturized interfaces — flexible polymer and endovascular systems replacing invasive metal arrays

    3. Closed-loop actuation — real-time robotic responses eliminating the human-in-the-loop latency bottleneck

    Critical Trajectory Observations:

    | Domain | Current State (2026) | 5-Year Horizon (2031) | Key Enabler |

    | Clinical BCIs | FDA-approved for ALS, locked-in syndrome, depression | Expanded to stroke rehabilitation, Parkinson’s | Regulatory pathways; AI decoding maturity |

    | Medical Micro-Robots | Preclinical trials in preclinical settings | First human trials (brain cancer, neurodegenerative) | Nanofabrication; blood-brain barrier penetration |

    | Humanoids | 60K+ global deployments; limited European adoption | 13M annual deployments; Europe’s niche in safety/precision | Cost reduction via “Three Bs” scaling |

    | Consumer Neurotech | EEG headsets for meditation/wellness | Continuous monitoring for cognitive health screening | Non-invasive resolution exceeding clinical thresholds |

    The European Advantage — Why It Matters:

    Europe won’t win the robotics race by copying US/Chinese playbooks. Instead, it’s positioning around:

    1. Safety & Regulation Expertise — The EU AI Act and Machinery Regulation create a certification advantage for compliant manufacturers

    2. Precision Engineering Heritage — Germany’s actuator dominance enables higher-precision robotic systems with better safety margins

    3. Regulatory Arbitrage Strategy — “Build fast, certify carefully” allows European startups to iterate rapidly before pursuing EU compliance

    4. Strategic Autonomy Investment — €30B+ French investment plan and EU-funded programs prioritize data residency and domestic supply chains

    Ethical & Governance Imperatives:

    1. Neural Data Privacy — Neural signals contain cognitive states, health conditions, and potentially unexpressed intentions. Cognitive liberty (right to mental self-determination) must be codified legally

    2. Equity of Access — Neurotechnology benefits are currently concentrated in high-income populations. Global health infrastructure must prevent neuro-inequality from becoming permanent

    3. Dual-Use Concerns — AI-native BCI architectures blur clinical and military applications. Governance frameworks must address this before deployment scales

    Prognosis:

    The trajectory beyond 2026 points toward whole-cortex recording, bidirectional sensory integration, and continuous neurological health monitoring. The market is transitioning from experimental novelty to practical infrastructure — millions now interact with some form of neural interface technology, whether medical implants or non-invasive headsets .

    Final Assessment: Brain robotics aren’t science fiction; they’re clinical reality. The question isn’t if they’ll save lives but how fast we can scale them equitably while establishing governance that protects the most vulnerable — both patients and society at large.

    #Airobots #Chatgpt #Robotics #BloombergTechnology #AI #artificialIntelligence #BCI #Brain #European #Humanoid #philosophy #physicalAI #technology
  23. China takes aim at Elon Musk’s ‘Jesus-level’ brain-chip dream with first BCI surgery policy

    Elon Musk has spent years pursuing what he has called “Jesus-level” technology through Neuralink, aiming to treat chronic…
    #UnitedStates #US #USA #brainimplants #brain-computerinterface #ChinaBCIsurgerypolicy #ElonMusk #ElonMuskbrainchip #Musk #Neuralinktechnology
    europesays.com/3192949/

  24. Why Virgin Olive Oil Might Be The Better Choice For Brain Health

    (Credit: DUSAN ZIDAR/Shutterstock) Virgin Olive Oil May Protect Aging Brains. Refined Oil May Not. In A Nutshell A two-year study of 656 older adults found that higher vi…
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #BRAIN #brainaging #brainhealth #Cognition #gutbacteria #Mediterranean #Olive #virginoliveoil
    diningandcooking.com/2769589/w

  25. Why Virgin Olive Oil Might Be The Better Choice For Brain Health

    (Credit: DUSAN ZIDAR/Shutterstock) Virgin Olive Oil May Protect Aging Brains. Refined Oil May Not. In A Nutshell A two-year study of 656 older adults found that higher vi…
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #BRAIN #brainaging #brainhealth #Cognition #gutbacteria #Mediterranean #Olive #virginoliveoil
    diningandcooking.com/2769589/w

  26. Why Virgin Olive Oil Might Be The Better Choice For Brain Health

    (Credit: DUSAN ZIDAR/Shutterstock) Virgin Olive Oil May Protect Aging Brains. Refined Oil May Not. In A Nutshell A two-year study of 656 older adults found that higher vi…
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #BRAIN #brainaging #brainhealth #Cognition #gutbacteria #Mediterranean #Olive #virginoliveoil
    diningandcooking.com/2769589/w

  27. Why Virgin Olive Oil Might Be The Better Choice For Brain Health

    (Credit: DUSAN ZIDAR/Shutterstock) Virgin Olive Oil May Protect Aging Brains. Refined Oil May Not. In A Nutshell A two-year study of 656 older adults found that higher vi…
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #BRAIN #brainaging #brainhealth #Cognition #gutbacteria #Mediterranean #Olive #virginoliveoil
    diningandcooking.com/2769589/w

  28. #MeditationPractices #MindfulnessFor #Brain Simple Ways to Add Mindfulness to Your Daily Routine: Even on busy days, you can discover moments throughout our day to practice awareness that can help add mindfulness into the things you do every single day.

    The post Simple Ways to Add Mindfulness to Your Daily Routine appeared first on Mindful. dlvr.it/TV0nth

  29. #MeditationPractices #MindfulnessFor #Brain Simple Ways to Add Mindfulness to Your Daily Routine: Even on busy days, you can discover moments throughout our day to practice awareness that can help add mindfulness into the things you do every single day.

    The post Simple Ways to Add Mindfulness to Your Daily Routine appeared first on Mindful. dlvr.it/TV0nth

  30. #MeditationPractices #MindfulnessFor #Brain Simple Ways to Add Mindfulness to Your Daily Routine: Even on busy days, you can discover moments throughout our day to practice awareness that can help add mindfulness into the things you do every single day.

    The post Simple Ways to Add Mindfulness to Your Daily Routine appeared first on Mindful. dlvr.it/TV0nth

  31. #MeditationPractices #MindfulnessFor #Brain Simple Ways to Add Mindfulness to Your Daily Routine: Even on busy days, you can discover moments throughout our day to practice awareness that can help add mindfulness into the things you do every single day.

    The post Simple Ways to Add Mindfulness to Your Daily Routine appeared first on Mindful. dlvr.it/TV0nth

  32. #MeditationPractices #MindfulnessFor #Brain Simple Ways to Add Mindfulness to Your Daily Routine: Even on busy days, you can discover moments throughout our day to practice awareness that can help add mindfulness into the things you do every single day.

    The post Simple Ways to Add Mindfulness to Your Daily Routine appeared first on Mindful. dlvr.it/TV0nth